Budget update and looking ahead to the federal election with Insight Strategy's Jody Fassina
Jody Fassina of Insight Strategy shares his thoughts on today's Budget update and the upcoming federal election. He discusses the implications for stakeholders, including the pharmaceutical sector, th...
15 Joulu 202132min
Amgen's Ian Noble - 'If it doesn't get measured, it doesn't get done'
Amgen's director of value, access and policy, Ian Noble, says Australia needs a clear vision to address the 820-day medicines 'access gap'.He says Amgen was disappointed with the report of the recent ...
13 Joulu 202123min
How the National Medicines Policy review is just exposing the problem
We discuss the claim Australia's most important document for medicines policy does not require a vision or overarching objective and why the National Medicines Policy review so far says everything peo...
11 Joulu 202125min
Dr Brendan Shaw - Australians now understand there is a 'queue' for new health technologies
Dr Brendan Shaw of Shawview Consulting discusses the findings of his report commissioned by Johnson & Johnson on 'Getting Australia to the front of the queue' when it comes to access to new medicines ...
6 Joulu 202133min
‘The things you can learn in 15 minutes - the power of parliamentary scrutiny’
The Senate backed the enabling legislation for the new PBS pricing framework but only after questioning from a key crossbencher that revealed more about the secret list of medicines used to calculate ...
1 Joulu 202121min
MA's Liz de Somer responds to the parliamentary inquiry report and looks ahead to 2022
The chief executive of Medicines Australia, Liz de Somer, discussed the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies, how the recommenda...
29 Marras 202131min
BeiGene's Adam Roach - 'Looking to change the conversation'
BeiGene's vice president of commercial for the Asia Pacific region Adam Roach discusses his background, career to date, disruption, as well as the company's plans for Australia and the region. He also...
28 Marras 202129min
The 'Zimmerman' inquiry - the good, the not so good and what now?
BioPharmaDispatch discusses the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies with Better Access Australia co-founder and chair Felicity ...
24 Marras 202133min
